These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy. Weger M; Stanger O; Deutschmann H; Simon M; Renner W; Schmut O; Semmelrock J; Haas A Br J Ophthalmol; 2001 Jul; 85(7):803-6. PubMed ID: 11423453 [TBL] [Abstract][Full Text] [Related]
43. Oral folate reduces plasma homocyst(e)ine levels in hemodialysis patients with cardiovascular disease. Stanford JL; Molina H; Phillips J; Kohlman-Trigoboff D; Moore J; Smith BM Cardiovasc Surg; 2000 Dec; 8(7):567-71. PubMed ID: 11068219 [TBL] [Abstract][Full Text] [Related]
45. Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. Sesmilo G; Biller BM; Llevadot J; Hayden D; Hanson G; Rifai N; Klibanski A J Clin Endocrinol Metab; 2001 Apr; 86(4):1518-24. PubMed ID: 11297577 [TBL] [Abstract][Full Text] [Related]
46. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate. Verhoef P; Stampfer MJ; Buring JE; Gaziano JM; Allen RH; Stabler SP; Reynolds RD; Kok FJ; Hennekens CH; Willett WC Am J Epidemiol; 1996 May; 143(9):845-59. PubMed ID: 8610698 [TBL] [Abstract][Full Text] [Related]
47. High plasma homocyst(e)ine levels in elderly Japanese patients are associated with increased cardiovascular disease risk independently from markers of coagulation activation and endothelial cell damage. Kario K; Duell PB; Matsuo T; Sakata T; Kato H; Shimada K; Miyata T Atherosclerosis; 2001 Aug; 157(2):441-9. PubMed ID: 11472745 [TBL] [Abstract][Full Text] [Related]
48. Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients. Del Ser T; Barba R; Herranz AS; Seijas V; López-Manglano C; Domingo J; Pondal M Cerebrovasc Dis; 2001 Aug; 12(2):91-8. PubMed ID: 11490102 [TBL] [Abstract][Full Text] [Related]
49. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. Taylor LM; DeFrang RD; Harris EJ; Porter JM J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384 [TBL] [Abstract][Full Text] [Related]
50. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke. Eikelboom JW; Hankey GJ; Anand SS; Lofthouse E; Staples N; Baker RI Stroke; 2000 May; 31(5):1069-75. PubMed ID: 10797167 [TBL] [Abstract][Full Text] [Related]
51. Homocysteine as a novel risk factor for atherosclerosis. Guthikonda S; Haynes WG Curr Opin Cardiol; 1999 Jul; 14(4):283-91. PubMed ID: 10448607 [TBL] [Abstract][Full Text] [Related]
52. Elevation of asymmetrical dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst(e)inaemia in humans. Böger RH; Lentz SR; Bode-Böger SM; Knapp HR; Haynes WG Clin Sci (Lond); 2001 Feb; 100(2):161-7. PubMed ID: 11171285 [TBL] [Abstract][Full Text] [Related]
53. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Kim MH; Kim E; Passen EL; Meyer J; Kang SS Metabolism; 1997 Mar; 46(3):247-9. PubMed ID: 9054464 [TBL] [Abstract][Full Text] [Related]
54. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia. Yoo JH; Choi GD; Kang SS Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1921-5. PubMed ID: 10938012 [TBL] [Abstract][Full Text] [Related]
55. Association between total homocyst(e)ine and the likelihood for a history of acute myocardial infarction by race and ethnicity: Results from the Third National Health and Nutrition Examination Survey. Giles WH; Croft JB; Greenlund KJ; Ford ES; Kittner SJ Am Heart J; 2000 Mar; 139(3):446-53. PubMed ID: 10689259 [TBL] [Abstract][Full Text] [Related]
56. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia. Manns B; Hyndman E; Burgess E; Parsons H; Schaefer J; Snyder F; Scott-Douglas N Kidney Int; 2001 Mar; 59(3):1103-9. PubMed ID: 11231366 [TBL] [Abstract][Full Text] [Related]
57. Oxidative stress in the context of acute cerebrovascular stroke. El Kossi MM; Zakhary MM Stroke; 2000 Aug; 31(8):1889-92. PubMed ID: 10926952 [TBL] [Abstract][Full Text] [Related]
58. Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms. Delport R; Lingenhel AW; Ubbink JB; Kraft HG Cardiovasc J S Afr; 2004; 15(5):207-13. PubMed ID: 15483732 [TBL] [Abstract][Full Text] [Related]
59. Association between homocyst(e)ine levels and risk of vascular events. Kaplan ED Drugs Today (Barc); 2003 Mar; 39(3):175-92. PubMed ID: 12730702 [TBL] [Abstract][Full Text] [Related]
60. Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum. Rajkovic A; Mahomed K; Malinow MR; Sorenson TK; Woelk GB; Williams MA Obstet Gynecol; 1999 Sep; 94(3):355-60. PubMed ID: 10472859 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]